Live Chat ×
Skip to main content

Light Chain (AL) Amyloidosis: What is AL Anyway?

Description

Amyloidosis Webinar

Contributors

  • Heather J. Landau, MD

    Heather J. Landau, MD is an Associate Attending Physician on the Adult Bone Marrow Transplant and Multiple Myeloma services at Memorial Sloan Kettering (MSK) Cancer Center and Assistant Professor of Medicine at Weill Cornell Medical College. She graduated Magna Cum Laude with a BS in Biology from Duke University where she first became interested in the field of Hematology and Oncology while studying Cell Biology. She received her MD from Upstate Medical University where she graduated first (vs Valedictorian) in her class. After an Internal Medicine Residency at the University of Colorado, she pursued her Hematology and Oncology Fellowship at MSK where she remains on faculty.

    Dr. Landau has dedicated her career to improving the outcomes of patients with plasma cell disorders including multiple myeloma (MM) and light chain (AL) amyloidosis. She has designed, implemented and participated in national and international clinical trials to enhance efficacy, facilitate access and increase tolerance of high dose therapy and autologous hematopoietic cell transplant. She has evaluated novel plasma cell directed and anti-amyloid therapies for patients with AL amyloidosis in order to establish safety, efficacy and increase organ recovery in this fragile patient population. She is a lead investigator on the pivotal trials expected to result in the first FDA approved drugs for this disease. Integrating genomic, proteomic and quality of life assessment tools, she is working to further advance the detection, risk stratification and management of patients with MM and AL Amyloidosis. She has received competitive funding for her work which has led to over 50 published articles and book chapters.

    At MSK, Dr. Landau developed an Outpatient Transplantation Program in 2011 which continues to thrive. More recently she piloted a Homebound Transplantation Program which is the first of its kind in an urban setting in North America and has been transformative for patients and caregivers’ quality of life. She has developed a multidisciplinary Amyloidosis Program at MSK that is internationally recognized. Mentoring residents and fellows who have gone on to seek academic appointments across the nation, her commitment to medical education has made far-reaching impact.

    As a thought leader in the world of plasma cell disorders, Dr. Landau is a sought after national and international speaker. She is heavily involved in several local, national and international societies. She serves on several committees within the Bone Marrow Transplant Clinical Trials Network, CIBMTR Plasma Cell Disorder working group, International Kidney Monoclonal Gammopathy working group and as an advisor to the Amyloidosis Research Consortium and the Amyloid Foundation.

    While she exhibits unwavering dedication to her patients and career, her greatest passion is her family including her husband Dan and her children Samantha, Harley, Saige and Xylie.



June 4, 2019
Tue 3:00 PM EDT

Duration 1H 30M

Already Registered?